Eupraxia Pharmaceuticals Inc. (EPRX) vs VectivBio Holding AG (VECT)

Eupraxia Pharmaceuticals Inc. and VectivBio Holding AG are both Biotechnology companies. Eupraxia Pharmaceuticals Inc. and VectivBio Holding AG are of similar size ($545.5M and $537.8M). Across the 9 metrics below, Eupraxia Pharmaceuticals Inc. leads on 7 and VectivBio Holding AG on 2.

Valuation

Metric EPRX VECT Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 5.30 3.94 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (12.73%) (27.42%) (28.84%)
Free cash flow yield (7.21%) (21.00%) (23.03%)

Profitability

Metric EPRX VECT Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (117.82%) (147.18%) (57.72%)
Return on assets (64.44%) (111.86%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric EPRX VECT Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (35.53%) 34.37% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric EPRX VECT Biotechnology median
Debt to equity 0.01 0.05 0.00
Current ratio 16.00 9.14 4.73
Net debt to EBITDA 2.11 2.63 0.96

Dividend

Metric EPRX VECT Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric EPRX VECT Biotechnology median
Market cap 537.83m 545.50m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack